Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten Beinema

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Thrombosis and Haemostasis|January 10, 2009
Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumonMaarten Beinema, Jacobus R B J Brouwers, Tom Schalekamp, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Thromboprophylaxis in total hip-replacement surgery in Europe: acenocoumarol, fondaparinux, dabigatran and rivaroxbanNatasa Ivanovic, Maarten Beinema, Jacobus Rbj Brouwers, et al.
European Journal of Clinical Pharmacology|July 11, 2025
Optimization of vitamin K antagonist treatment: Near patient monitoring versus standard of care a parallel group clinical trial in older patients with atrial fibrillationMargriet van Elp, Maarten Beinema, Jacobus R B J Brouwers, et al.
Research and Practice in Thrombosis and Haemostasis|September 24, 2025
Changes in quality of vitamin K antagonist treatment and clinical outcomes during Ramadan: a Dutch population-based cohort studyEva K Kempers, Qingui Chen, Nienke van Rein, et al.
Thrombosis and Haemostasis|January 2, 2026
Anticoagulation therapeutic ranges and clinical outcomes in patients with a mechanical heart valve treated with vitamin K antagonistsChantal Visser, Eva Kempers, Jaap Seelig, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Thrombosis and Haemostasis|January 10, 2009
Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumonMaarten Beinema, Jacobus R B J Brouwers, Tom Schalekamp, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Thromboprophylaxis in total hip-replacement surgery in Europe: acenocoumarol, fondaparinux, dabigatran and rivaroxbanNatasa Ivanovic, Maarten Beinema, Jacobus Rbj Brouwers, et al.
European Journal of Clinical Pharmacology|July 11, 2025
Optimization of vitamin K antagonist treatment: Near patient monitoring versus standard of care a parallel group clinical trial in older patients with atrial fibrillationMargriet van Elp, Maarten Beinema, Jacobus R B J Brouwers, et al.
Research and Practice in Thrombosis and Haemostasis|September 24, 2025
Changes in quality of vitamin K antagonist treatment and clinical outcomes during Ramadan: a Dutch population-based cohort studyEva K Kempers, Qingui Chen, Nienke van Rein, et al.
Thrombosis and Haemostasis|January 2, 2026
Anticoagulation therapeutic ranges and clinical outcomes in patients with a mechanical heart valve treated with vitamin K antagonistsChantal Visser, Eva Kempers, Jaap Seelig, et al.
Pageof 1